Tango Therapeutics files amended 8-K on executive chair transition

• Tango Therapeutics filed an amended Form 8-K to update disclosure on a leadership change.
• Executive Chair Barbara Weber will step down from the board in connection with other pursuits.
• The amendment frames the transition as a governance change with no financial terms disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-339070), on August 07, 2026, and is solely responsible for the information contained therein.